News

Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical ...
Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...
Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, ...
Sanofi announces extension of Blueprint tender offer Paris, July 17, 2025. Sanofi today announces that Rothko Merger Sub, Inc., a wholly owned subsidiary of Sanofi, has extended the expiration date of ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product ...
Mumbai: Sanofi India has appointed Rachid Ayari as its Interim Managing Director, while continuing in his current role as Chief Financial Officer (CFO). Ayari will hold the dual role for ...
In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile ...
Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...
Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...
Sanofi is a high-quality, undervalued pharma giant trading near 10x P/E. Click here to read more about SNY stock and why it ...
Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, N.J. The science-services and instruments provider said Wednesday that it ...
Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration. The French drugmaker said ...